title: Suspected rapid-onset neutropenia following etanercept use: disproved following rechallenge and lessons to be learned.
authors.affiliation: Department of Neurology Thomas Jefferson University Hospital Philadelphia PA USA Department of Dermatology Henry Ford Hospital Detroit MI USA E-mail: tshwayd1@hfhs.org.
authors.forename: Amit
authors.initials: A
authors.lastname: Sachdev
authors.forename: Tor
authors.initials: T
authors.lastname: Shwayder
mesh_terms: D002648:Child; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D009503:Neutropenia / Q000139:chemically induced*; D011565:Psoriasis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept